Dr Agarwal's Eye Hospital Q1 FY27 PAT up 35.5 percent, revenue up 22 percent YoY

Revenue growth above 20%Profit growth above 25%Results View source PDF Explain this filing

DRAGARWQ · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.4%Reaction day

₹5048.50

prior close

₹5199.50

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-0.0% vs market

Hospital peers, median of 26sector+0.1%+0.3% vs sector

On the reaction day the stock moved in line with Nifty Microcap 250 and 0.3 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.9

10m

+1.0

15m

+0.0

30m

-1.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.4+0.4-0.0+0.1+0.3

Next day

+3.0+1.7+1.3+0.0+3.0

+4.1+2.1+2.0+0.2+3.9

+4.2+2.1+2.1+1.2+2.9

+7.0+2.1+4.9+1.0+5.9

+5.5+1.9+3.7-0.7+6.2

+6.0+2.4+3.5-2.2+8.1

15d

+5.2+3.0+2.2-1.5+6.7

+8.0+3.7+4.2-2.9+10.8

+4.0+1.6+2.4-9.2+13.2

—————

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q1 FY27 results - revenue from operations Rs 142.97 cr (+22.3% YoY), net profit Rs 23.38 cr (+35.5% YoY), EBITDA Rs 45.22 cr. EPS Rs 48.38 versus Rs 36.72. Statutory auditor issued clean limited review report. Also reappointed B Y and Associates as cost auditors for FY27. Amalgamation scheme with holding company AHCL awaits NCLT sanction.

Likely market impact

Strong double-digit growth in revenue and profit signals healthy business momentum for shareholders.